Admelog Insulin Lispro — Rapid-Acting Analogue 100iu

How it works 
As a lispro analogue, Admelog has a modified amino-acid sequence that speeds absorption after subcutaneous injection. It rapidly lowers post-meal blood glucose by promoting peripheral glucose uptake and reducing hepatic glucose output.

Onset • Peak • Duration (typical)

• Onset: ≈ 10–20 minutes (faster than regular insulin)

• Peak: ≈ 1–2 hours

• Duration: ≈ 3–5 hours
  (Exact timing varies by individual, injection site, and dose.)

Formulations & concentration

• Commonly available as U-100 in vials and prefilled pens.

Storage & handling (general guidance)

• Unopened: Refrigerate (2–8°C) until expiration; do not freeze.

• After first use: Many manufacturers state pens/vials can be kept at room temperature (commonly up to 28 days) — follow the Admelog prescribing information for exact storage time and temperature.

• Keep away from heat and light.

Common side effects & safety

• Hypoglycemia is the main risk, especially if meal timing or carbohydrate intake is mismatched.

• Injection-site reactions and lipohypertrophy (rotate sites).

• Weight gain possible.

• Rare allergic reactions.

• Use caution if driving or operating heavy machinery until you understand how Admelog affects you.

Drug interactions & precautions

• Other drugs (steroids, beta-blockers, some antibiotics) can affect blood glucose responses. Always coordinate medication changes with your healthcare provider.

• Adjustments may be required for renal or hepatic impairment.

Practical notes

• Rapid onset makes timing critical — typically injected immediately before or just after a meal per prescriber instruction.

• Dosing must be individualized using glucose monitoring and carbohydrate counting where applicable.